Metagenomics Market is expected to reach US$ 314.3 Mn by 2027


PRESS RELEASE BY The Insight Partners 30 Jan 2019

Share this press on


Consumables Segment by Product Dominated the Metagenomics Market During 2019–2027

According to our new research study on "Metagenomics Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Product and Application," the market was valued at US$ 165.8 million in 2018 and is expected to reach US$ 314.3 million by 2027; it is estimated to record a CAGR of 7.7% from 2019–2027. The report highlights the trends and drivers prevailing in the market.

Based on product, the metagenomics market size is bifurcated into instruments & software, and consumables. The consumables segment held the larger share of the market in 2018. The increase in research and research projects along with large scale collaborations in different industries such as environment, food, healthcare, and others has created huge demand for consumables. The ongoing different research also requires the consumables and kits in large quantity and there are various market players that offers reagents kits and other consumables that are required for the metagenomics. For instance, Illumina inc., offers MiSeq v3 Reagents Kits, MiSeq v2 Reagents Kits, NextSeq 500/550 v2 Kits, HiSeq 4000 SBS Kit and PE Cluster Kit. Perkin Elmer Inc offers NEXTflex library preparation kits which include NEXTflex 16S and 18S Amplicon-Seq Kits. Similarly, Merck KGaA offers broad array of qPCR kits and probes for all detection chemistries and all instrument platforms. The portfolio includes standard qPCR kits, Capillary tube qPCR kits, high-throughput qPCR kits and one-step qRT-PCR kits among the others. 

Metagenomics Market, by Region, 2019 (%)

Metagenomics Market, by Region, 2019 (%)


Metagenomics Market Growth Report & Global Trends 2028

Download Free Sample

Metagenomics Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product (Instruments & Software and Consumables) and Application (Clinical Diagnostics, Drug Discovery Metagenomics, and Others)

Source: The Insight Partners Analysis

Moreover, the application of metagenomics and microbiome are used in the medical research, agriculture research and environmental research. This research is widely used in metagenomics genomics for the 16SrRNA Gene Sanger Sequencing, Metagenomics Solutions and Whole Genome Sequencing. Therefore, the extensive demand for the consumables is likely to anticipate the metagenomics market growth in the near future.

Based on application, the metagenomics market size is categorized into clinical diagnostics, drug discovery metagenomics, and others. The clinical diagnostics segmented held the largest market share and anticipated to register the highest CAGR in the coming years. Based on geography, the metagenomics market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, the Netherlands, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, Thailand, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Impact of the COVID-19 Pandemic on the Metagenomics Market
The COVID-19 pandemic had a huge impact on the regions across the globe as it tested the resilience of economies and placed immense pressure on health workers. A socio-economic analysis of the impact of the pandemic by the United Nations Development Programme (UNDP) helped governments of various countries overhaul policies and invest in public health, economic stimulus, and social safety. These measures helped countries recover faster from the adversities caused by the COVID-19 crisis. Governments of various countries ensured the uninterrupted availability of life-supporting medical equipment. The COVID-19 pandemic altered economic conditions and social behaviors in North American countries. Containment measures enacted by the US government to mitigate the spread of SARS-CoV-2 changed the pattern of healthcare service delivery in the country. According to the Department of Emergency Medicine, in many cities across the US, emergency department (ED) visits decreased by ~40% in 2020. The healthcare professionals have also cancelled the elective surgical procedures and only prioritize the emergency procedures. The research organization had put their ongoing work aside to focus on the pandemic and started new research for the diagnosis and treatment of the COVID-19 infection. Additionally, the metagenomics market had witnessed the sudden shortfall in consumables in the initial phase of pandemic owing to the disruption in supply chain and production which was resolved in a very short span of time. Therefore, there was a short-term impact of the COVID-19 pandemic on the global metagenomics market growth.

Contact Us
 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com

 

Download Free PDF Brochure